Doctors Share The Habits They Changed After Seeing Patients Suffer
People who work in medical professions, like doctors, nurses, and EMTs, often see firsthand what can happen to…
The new GLP-1 weight-loss pill vs. the shot: a doctor’s answer on oral Wegovy
FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China
HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
Influenza A surge: Flu patients face corridor beds and 10-hour waits
“They are so incredibly under-resourced,” she said. In the past fortnight, a surge of influenza A cases has…
EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
The new GLP-1 weight-loss pill vs. the shot: A doctor’s honest answer on oral Wegovy
FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
JB hospital sees surge in Singapore patients using MediSave for treatment
LOOK BEYOND STICKER PRICE, SAYS EXPERT Lower treatment costs are a significant draw for patients considering healthcare procedures…
US Nurse Fired Over Video Suggesting She Avoids Patients Watching Fox News
The University of Texas Medical Branch (UTMB) has fired a nurse after investigating a viral social media video…
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
The new weight-loss pill vs. the shot: A doctor’s honest answer on oral Wegovy
When the FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025…
Nurse banned after poor English put patients at risk
A woman was banned from working as an NHS nurse after her poor understanding of the English language…
Nutex Health’s incredible rebound rests on two regulatory gray areas
Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices…